1,101 posts by 291 firms and lawyers
Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.
Ohio’s attempt to move federally lawful hemp products into its closed marijuana market has now produced three federal preliminary injunctions and an expedited appeal to the Sixth Circuit Court of Appeals. These cases are…
The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests…
In the iconic halftime scene of Friday Night Lights, Coach Gary Gaines (played with a charming ferocity the way only Billy Bob Thornton could muster) looks his team in the eyes and tells them they have exactly “two more quarters…
If you aren’t familiar with marijuana, or you’re not a botanist, you may not know that hemp and marijuana are the same plant. Not similar. Not cousins. , separated by a legal distinction so arbitrary it would be funny if it…
Congress finally has a serious bipartisan alternative to the federal hemp ban scheduled to take effect this November.
The hearing on the Notice of Proposed Rulemaking for the rescheduling of “marijuana” commenced on June 29, 2026 and will end tomorrow, July 15th. The Government brought two witnesses to the stand on the first day, and then seven…
With SF 4401, the state did not leave the hemp industry stranded while the broader cannabis market moves on. It did not wall off hemp operators and tell them to fend for themselves.
On April 23rd, the DEA issued a final order moving certain marijuana classifications from Schedule I to Schedule III of the Controlled Substances Act (CSA).
The DEA has now done what many in the hemp industry feared it would: it specifically listed hexahydrocannabinol, or HHC, in Schedule I and assigned it its own DEA drug code, effective May 4, 2026. The position is not subtle.
Dr. Marty Makary resigned as FDA commissioner last week, barely a year after his Senate confirmation. HHS Secretary Robert F. Kennedy Jr. confirmed the departure and indicated the agency is searching for a replacement.
November 12, 2026 is not an abstraction. S. National Cannabinoid Report. It will also recriminalize products that millions of Americans use daily for sleep, anxiety, and relaxation — products that are, by any rational measure,…
Few industries in recent American history have climbed so fast or stand to fall so hard. 375 billion in annual sales by 2025. Craft breweries, alcohol veterans, and cannabis entrepreneurs bet big on a category that consumers…
Ohio Gov. Mike DeWine signed, but partially vetoed, a bill (S.B. 56) that effectively recriminalizes certain intoxicating hemp beverages as of March 20, 2026. Specifically, hemp beverages may no longer contain more than .3% of…
” The general thrust is FDA’s assurance that it won’t interfere with a new federal initiative, which covers up to $500 of hemp-derived products for eligible Medicare patients.
2026 brings cautious, steady progress in a continually evolving regulatory and commercial landscape. Stakeholders should expect ongoing change across policy, markets, compliance, and enforcement, creating both risks and…
Federal cannabis policy is entering a period of transition. Executive action toward federal rescheduling under the Controlled Substances Act, ongoing constitutional litigation, and congressional efforts to amend the federal…
A fast-growing market built on hemp-derived cannabinoid products is about to face a federal reset. Over the past several years, consumer demand for products such as hemp-derived THC gummies, beverages, vapes, and flowers helped…
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that directs the Attorney General in the most expeditious manner in accordance with federal law, to…
On December 18, 2025, President Trump issued an executive order directing his administration to complete the process for reclassifying marijuana under the federal Controlled Substances Act, moving it from Schedule I to Schedule…
C. ” The announcement was made during an Oval Office meeting with Health and Human Services Secretary Kennedy, senior administration officials, doctors and veterans who advocate for increased access to medical cannabis.